ClinicalThere is a statistically significant, but not clinically significant, increase in patients who have a lower reduction in mobility score (less loss of mobility) at 12 months (LOW QUALITY).

There is a statistically significant, but not clinically significant, decrease in patients who reported pain at 3 months (LOW QUALITY) and 1 to 2 years (MODERATE QUALITY). However, there was no significant difference in a pain score at 6 months (LOW QUALITY).

There is no statistically significant difference in perioperative mortality (LOW QUALITY), mortality at 3 months (LOW QUALITY) or 1 year (MODERATE QUALITY), failure to return home (MODERATE QUALITY), length of hospital stay (LOW QUALITY), number of patients requiring reoperations (LOW QUALITY), number of patients failing to regain mobility (LOW QUALITY), deep sepsis (MODERATE QUALITY), wound haematoma (MODERATE QUALITY) and all medical complications combined (VERY LOW QUALITY).

No RCT evidence was identified reporting quality of life, total length of stay to community resettlement or place of residence after hip fracture

No RCT evidence was identified to suggest there is a safety issue with using cement.
EconomicCemented hemiarthroplasty is cost saving compared to uncemented hemiarthroplasty. This evidence has potentially serious limitations and partial applicability.

From: 10, Surgical procedures

Cover of The Management of Hip Fracture in Adults
The Management of Hip Fracture in Adults [Internet].
NICE Clinical Guidelines, No. 124.
National Clinical Guideline Centre (UK).
Copyright © 2011, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.